Compare Ocumetics Technology Corp. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 22 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.03
109.25%
-5.73
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2025)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-41.89%
0%
-41.89%
6 Months
-69.29%
0%
-69.29%
1 Year
40.98%
0%
40.98%
2 Years
40.98%
0%
40.98%
3 Years
19.44%
0%
19.44%
4 Years
30.3%
0%
30.3%
5 Years
1620.0%
0%
1620.0%
Ocumetics Technology Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-214.17%
EBIT to Interest (avg)
-2.30
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.14
Sales to Capital Employed (avg)
0
Tax Ratio
1.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-5.73
EV to EBIT
-8.80
EV to EBITDA
-9.23
EV to Capital Employed
26.28
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-298.49%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.90
-0.50
-80.00%
Interest
0.40
0.20
100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.30
-0.80
-62.50%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -62.50% vs -14.29% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-2.30
-3.50
34.29%
Interest
0.60
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.00
-3.60
16.67%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 16.67% vs -63.64% in Dec 2023
About Ocumetics Technology Corp. 
Ocumetics Technology Corp.
Pharmaceuticals & Biotechnology
Quantum Blockchain Technologies Ltd is Canada-based capital pool company, focused on identifying and evaluating businesses or assets with a view to completing a Qualifying Transaction.






